Thursday, Sep 28, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Zydus Gets Final Usfda Approval To Market Roflumilast Tablets

Zydus gets final USFDA approval to market Roflumilast tablets

New Delhi: Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations. Zydus, being one of the first […]

By PTI
Published Date - 01:34 PM, Mon - 14 February 22
Zydus gets final USFDA approval to market Roflumilast tablets
Source: IANS
whatsapp facebook twitter telegram

New Delhi: Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations.

Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug exclusivity, Cadlia Healthcare said in a regulatory filing.
The US Food and Drug Administration (USFDA) has also given a tentative approval for Roflumilast tablets, 250 mcg, the company added.

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.

Roflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations, it added.

The group now has 327 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • Ahmedabad
  • Cadlia Healthcare
  • pulmonary disease
  • Roflumilast tablets

Related News

  • Kartavya Anadkat emerges chess champion at Brilliant Trophy Open Online Chess Tournament

    Kartavya Anadkat emerges chess champion at Brilliant Trophy Open Online Chess Tournament

  • Gujarat records 886.03 mm rainfall

    Gujarat records 886.03 mm rainfall

  • Lulu Group to set up large shopping mall in Ahmedabad, Chennai

    Lulu Group to set up large shopping mall in Ahmedabad, Chennai

  • Unhappy over daughter’s love marriage, family of 4 consume poison in Gujarat

    Unhappy over daughter’s love marriage, family of 4 consume poison in Gujarat

  • Ahmedabad: Youth fires shots near police station, investigation launched

    Ahmedabad: Youth fires shots near police station, investigation launched

  • Nine guns seized, three arrested in Ahmedabad

    Nine guns seized, three arrested in Ahmedabad

Latest News

  • PM Modi pays tribute to Lata Mangeshkar on her birth anniversary

    15 seconds ago
  • US Embassy in India surpasses goal of processing one million non-immigrant visas

    9 mins ago
  • Hyderabad: Pakistan Captain Babar Azam touched by Indian fans’ support for World Cup 2023

    13 mins ago
  • Bihar: Nitish angered by English display board at school library

    16 mins ago
  • Joe Jonas, Sophie Turner debate over divorce proceedings location

    24 mins ago
  • BJP central leadership in hectic parleys with AIADMK through mediators

    31 mins ago
  • Delhi Police register case for Pro-Khalistani graffiti under Kashmiri gate flyover

    34 mins ago
  • Indian-American presidential aspirant Vivek Ramaswamy attacked by rivals over Ukraine

    41 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam